Risk stratification based on a prognostic factor index among patients with HR+, HER2- MBC.

Gregory A. Vidal,Gebra Cuyun Carter,Adrienne M. Gilligan,KR Saverno,Yajun Emily Zhu,Gregory L Price,Angelo DeLuca,Emily Nash Smyth,Andrew Koustenis,Yu-Jing Huang,Lee S. Schwartzberg

Risk stratification based on a prognostic factor index among patients with HR+, HER2- MBC.

2019

Gregory A. Vidal
Gebra Cuyun Carter
Adrienne M. Gilligan
KR Saverno
Yajun Emily Zhu
Gregory L Price
Angelo DeLuca
Emily Nash Smyth
Andrew Koustenis
Yu-Jing Huang
Lee S. Schwartzberg

e12516Background: Patient and tumor characteristics, such as tumor grade (TG), site of metastases, hormone receptor status, and endocrine resistance, affect the prognosis for patients (pts) with HR...

Keywords:

Hormone receptor
Endocrine system
Oncology
Pathology
Medicine
Internal medicine
endocrine resistance
prognostic factor
risk stratification
tumor grade

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations